Opinion & Analysis
Pharmaceutical Industry Seeks to Thwart State Initiatives to Tackle Unaffordability of Prescription Drugs
Aiseosa Osaghae Sheela Ranganathan
Fifth Circuit Ruling Allows Industry Challenge To Drug Negotiation Program
Zachary L. Baron Leora Friedman
Legal Challenges Against ACA’s Section 1557 Anti-Discrimination Protections
Aiseosa Osaghae Andrew J. Twinamatsiko
Administration Announces Medicare Negotiated Prices as Courts Continue to Reject Challenges to the Program
Leora Friedman Zachary L. Baron
Cancer Screenings and Other Preventive Services at Risk in Fifth Circuit Decision
Andrew J. Twinamatsiko Lawrence O. Gostin Aiseosa Osaghae
Threats to EMTALA: Unpacking the Oral Arguments in Idaho v. United States
Sheela Ranganathan Rebecca Reingold Emily Schneider
FDA v. Alliance for Hippocratic Medicine: Recapping the Supreme Court’s Oral Argument
Suhasini Ravi Rebecca Reingold
Unpacking Recent Antitrust Challenges to Private Equity in Health Care
Sheela Ranganathan Emily Schneider
Challengers to Medicare Drug Price Negotiation Program Suffer Major Defeat
Zachary L. Baron Suhasini Ravi
Policy Dispute Masquerading As Constitutional Theory? Due Process Attacks on Medicare Drug Negotiation Program
Andrew J. Twinamatsiko Zachary L. Baron
How Recent Litigation Undermines Efforts to Advance Health Equity in the U.S.
Andrew J. Twinamatsiko Zachary L. Baron Madison Fields Emily Schneider
Third Circuit Issues Major Decision That Could Shift 340B Landscape
Andrew J. Twinamatsiko Zachary L. Baron
Supreme Court Slashes Remedies for Victims of Health Care Discrimination
Katie Keith Joseph Wardenski